Brittany Bradrick
Direktor/Vorstandsmitglied bei DERMATA THERAPEUTICS, INC.
Vermögen: 498 $ am 30.04.2024
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| David Hale | M | 75 |
Neurelis, Inc.
 Neurelis, Inc. Pharmaceuticals: MajorHealth Technology Neurelis, Inc. operates as a specialty pharmaceutical company. It is organized to license, develop and commercialize product candidates for the treatment of central nervous system disorders with a focus on the acute treatment of epilepsy and anxiety episodes. The company was founded by Craig C. Chambliss and David F. Hale in 2007 and is headquartered in San Diego, CA. | 17 Jahre |
| Gerry Proehl | M | 65 | 10 Jahre | |
| Craig Charles Chambliss | M | - |
Neurelis, Inc.
Neurelis, Inc. Pharmaceuticals: MajorHealth Technology Neurelis, Inc. operates as a specialty pharmaceutical company. It is organized to license, develop and commercialize product candidates for the treatment of central nervous system disorders with a focus on the acute treatment of epilepsy and anxiety episodes. The company was founded by Craig C. Chambliss and David F. Hale in 2007 and is headquartered in San Diego, CA. | 17 Jahre |
| James Hollingshead | M | 61 | 5 Jahre | |
| Lauren Budden | F | 49 | 5 Jahre | |
| Kathleen Scott | F | 55 | 3 Jahre | |
| Sean Proehl | M | - | 3 Jahre | |
| Eric Benjamin | M | 41 | 6 Jahre | |
| Enrique Carrazana | M | 62 |
Neurelis, Inc.
Neurelis, Inc. Pharmaceuticals: MajorHealth Technology Neurelis, Inc. operates as a specialty pharmaceutical company. It is organized to license, develop and commercialize product candidates for the treatment of central nervous system disorders with a focus on the acute treatment of epilepsy and anxiety episodes. The company was founded by Craig C. Chambliss and David F. Hale in 2007 and is headquartered in San Diego, CA. | 4 Jahre |
| Stephen H. Jenner | M | 56 |
Neurelis, Inc.
Neurelis, Inc. Pharmaceuticals: MajorHealth Technology Neurelis, Inc. operates as a specialty pharmaceutical company. It is organized to license, develop and commercialize product candidates for the treatment of central nervous system disorders with a focus on the acute treatment of epilepsy and anxiety episodes. The company was founded by Craig C. Chambliss and David F. Hale in 2007 and is headquartered in San Diego, CA. | 5 Jahre |
| Corinne Nevinny | F | 64 | 5 Jahre | |
| Andrew Sandler | M | 58 | 3 Jahre | |
| John Kapples | M | 64 | 5 Jahre | |
| Michael Minogue | M | 57 | 7 Jahre | |
| Kevin Kaijun Li | M | - |
Neurelis, Inc.
Neurelis, Inc. Pharmaceuticals: MajorHealth Technology Neurelis, Inc. operates as a specialty pharmaceutical company. It is organized to license, develop and commercialize product candidates for the treatment of central nervous system disorders with a focus on the acute treatment of epilepsy and anxiety episodes. The company was founded by Craig C. Chambliss and David F. Hale in 2007 and is headquartered in San Diego, CA. | - |
| Mary Fisher | F | 62 | 3 Jahre | |
| Wendell Wierenga | M | 76 | 8 Jahre | |
| Steven Mento | M | 72 | 3 Jahre | |
| Angela Wiczek | F | - | 4 Jahre | |
| Christopher Nardo | M | 59 | 9 Jahre | |
| Kyri van Hoose | M | - | 3 Jahre | |
| Dan Manea | M | 57 | 4 Jahre | |
| Trang Ly | M | - | 8 Jahre | |
| Steve Cartt | M | 61 |
Neurelis, Inc.
Neurelis, Inc. Pharmaceuticals: MajorHealth Technology Neurelis, Inc. operates as a specialty pharmaceutical company. It is organized to license, develop and commercialize product candidates for the treatment of central nervous system disorders with a focus on the acute treatment of epilepsy and anxiety episodes. The company was founded by Craig C. Chambliss and David F. Hale in 2007 and is headquartered in San Diego, CA. | 4 Jahre |
| Maria Bedoya-Toro Munera | M | 72 | 8 Jahre | |
| Thomas Liquard | M | 51 |
Neurelis, Inc.
Neurelis, Inc. Pharmaceuticals: MajorHealth Technology Neurelis, Inc. operates as a specialty pharmaceutical company. It is organized to license, develop and commercialize product candidates for the treatment of central nervous system disorders with a focus on the acute treatment of epilepsy and anxiety episodes. The company was founded by Craig C. Chambliss and David F. Hale in 2007 and is headquartered in San Diego, CA. | 7 Jahre |
| Huai Zheng Peng | M | 62 |
Neurelis, Inc.
Neurelis, Inc. Pharmaceuticals: MajorHealth Technology Neurelis, Inc. operates as a specialty pharmaceutical company. It is organized to license, develop and commercialize product candidates for the treatment of central nervous system disorders with a focus on the acute treatment of epilepsy and anxiety episodes. The company was founded by Craig C. Chambliss and David F. Hale in 2007 and is headquartered in San Diego, CA. | - |
| David Smith | M | 64 |
Neurelis, Inc.
Neurelis, Inc. Pharmaceuticals: MajorHealth Technology Neurelis, Inc. operates as a specialty pharmaceutical company. It is organized to license, develop and commercialize product candidates for the treatment of central nervous system disorders with a focus on the acute treatment of epilepsy and anxiety episodes. The company was founded by Craig C. Chambliss and David F. Hale in 2007 and is headquartered in San Diego, CA. | 3 Jahre |
| Priyanka Belawat | M | 45 |
Neurelis, Inc.
Neurelis, Inc. Pharmaceuticals: MajorHealth Technology Neurelis, Inc. operates as a specialty pharmaceutical company. It is organized to license, develop and commercialize product candidates for the treatment of central nervous system disorders with a focus on the acute treatment of epilepsy and anxiety episodes. The company was founded by Craig C. Chambliss and David F. Hale in 2007 and is headquartered in San Diego, CA. | - |
| Mark Field | M | 53 | 5 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Thomas Riga | M | 48 | 10 Jahre | |
| Patrick Sullivan | M | 72 | 5 Jahre | |
| Wayde McMillan | M | 54 | 4 Jahre | |
| Michael Levitz | M | 50 | 4 Jahre | |
| Daniel Levangie | M | 73 | 6 Jahre | |
| Paul Laikind | M | 68 |
ViaCyte, Inc.
 ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology ViaCyte, Inc. develops a stem cell-derived islet replacement therapy for the treatment of diabetes. Its development portfolio includes VC-01 product candidate, a cell replacement therapy for the treatment of type 1 diabetes. The company was founded in 1999 and is headquartered in San Diego, CA. | 8 Jahre |
| Michael Yang | M | 62 |
ViaCyte, Inc.
ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology ViaCyte, Inc. develops a stem cell-derived islet replacement therapy for the treatment of diabetes. Its development portfolio includes VC-01 product candidate, a cell replacement therapy for the treatment of type 1 diabetes. The company was founded in 1999 and is headquartered in San Diego, CA. | - |
| Regina Sommer | F | 66 | 9 Jahre | |
| Jeffrey Vacirca | M | 55 | 5 Jahre | |
| Dolatrai Vyas | M | 80 | 9 Jahre | |
| William Ashton | M | 73 | 5 Jahre | |
| David Colleran | M | 52 | 4 Jahre | |
| Joseph Zakrzewski | M | 60 | 9 Jahre | |
| Ju-Hyun Lim | F | 49 | 1 Jahre | |
| James Mullen | M | 65 | 2 Jahre | |
| Annette Matthies | M | 47 |
Abbott Laboratories, Inc.
 Abbott Laboratories, Inc. Medical SpecialtiesHealth Technology Part of Abbott Laboratories, Inc., the company manufactures and wholesales diagnostic and pharmaceutical products as well as medical devices. The company is based in Chicago, IL. | 1 Jahre |
| Cheng Peiling | M | - | 1 Jahre | |
| Jeffrey Kent | M | 62 |
Abbott Laboratories, Inc.
Abbott Laboratories, Inc. Medical SpecialtiesHealth Technology Part of Abbott Laboratories, Inc., the company manufactures and wholesales diagnostic and pharmaceutical products as well as medical devices. The company is based in Chicago, IL. | 8 Jahre |
| Kathy V. Turner | F | 60 |
Abbott Laboratories, Inc.
Abbott Laboratories, Inc. Medical SpecialtiesHealth Technology Part of Abbott Laboratories, Inc., the company manufactures and wholesales diagnostic and pharmaceutical products as well as medical devices. The company is based in Chicago, IL. | 25 Jahre |
| Bret Christensen | M | 53 | 6 Jahre | |
| Ethan Butler | M | - | 2 Jahre | |
| Francois Lebel | M | 72 | 4 Jahre | |
| Aiman Abdel-Malek | M | 65 | 3 Jahre | |
| Mark Licari | M | - | 2 Jahre | |
| Christopher Gilbert | M | - | 5 Jahre | |
| Frédéric Jacotot | M | 60 |
Abbott Laboratories, Inc.
Abbott Laboratories, Inc. Medical SpecialtiesHealth Technology Part of Abbott Laboratories, Inc., the company manufactures and wholesales diagnostic and pharmaceutical products as well as medical devices. The company is based in Chicago, IL. | 3 Jahre |
| Brad Thomas | M | - | 4 Jahre | |
| Shanta P. Chawla | M | 76 | - | |
| Kevin D'Amour | M | 51 |
ViaCyte, Inc.
ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology ViaCyte, Inc. develops a stem cell-derived islet replacement therapy for the treatment of diabetes. Its development portfolio includes VC-01 product candidate, a cell replacement therapy for the treatment of type 1 diabetes. The company was founded in 1999 and is headquartered in San Diego, CA. | - |
| Adam Koppel | M | 54 |
ViaCyte, Inc.
ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology ViaCyte, Inc. develops a stem cell-derived islet replacement therapy for the treatment of diabetes. Its development portfolio includes VC-01 product candidate, a cell replacement therapy for the treatment of type 1 diabetes. The company was founded in 1999 and is headquartered in San Diego, CA. | 3 Jahre |
| Seth Fischer | M | 68 | 3 Jahre | |
| Timothy Kieffer | M | 58 |
ViaCyte, Inc.
ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology ViaCyte, Inc. develops a stem cell-derived islet replacement therapy for the treatment of diabetes. Its development portfolio includes VC-01 product candidate, a cell replacement therapy for the treatment of type 1 diabetes. The company was founded in 1999 and is headquartered in San Diego, CA. | 1 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigte Staaten | 62 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Brittany Bradrick
- Persönliches Netzwerk
